Maximal antiplatelet therapy with prasugrel and GP IIb/IIIa-receptor antagonists in ST-elevation myocardial infarctions is not associated with high acute bleeding rates in clinical practice | Zendy

AI Assistant Blog Pricing

Maximal antiplatelet therapy with prasugrel and GP IIb/IIIa-receptor antagonists in ST-elevation myocardial infarctions is not associated with high acute bleeding rates in clinical practice

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.